PM360 2018 Innovative Startup MedBlox, Inc.

MedBlox, Inc.

Somchai Rice, Co-Founder & Chief Science Officer
s.rice@medblox.io

Physicians are spending 11.8 minutes directly interacting with a patient per visit, 8.3 minutes interacting with the electronic health record (EHR) system during the patient’s visit, and 10.6 minutes interacting with the EHR system outside of the patient’s visit. This results in 18.9 minutes spent on EHR, or 62% of a physician’s time, according to The Harris Poll conducted on behalf of Stanford Medicine. While wide adoption of EHR was supposed to lead to unshackled patient health information and more time with patients, instead patient-doctor interaction has decreased.

MedBlox seeks to overcome the current hurdles in EHR through improved (1) Interoperability; (2) Data security; (3) Lack of clear regulation; and (4) Availability. MedBlox is designed to fulfill the criteria necessary to increase interoperability, which includes a data exchange that can be open to everyone, and the ability to cut across borders. MedBlox-distributed ledger technology is designed to securely store, share, and sustain EHRs in a validated and certified manner—all while leaving the health record owner, the patient, in complete control. MedBlox ensures data security with complete anonymity and trust to ensure we all play a part in molding the next-generation of healthcare innovators. MedBlox has also designed a secured transfer of ownership process to account for the bulk transitions of data from a provider to patient.

The company was incorporated in July 2018. MedBlox has validated the platform for the architecture and continued development of standardized data feed/ingestion and is continuing app development. The platform is not currently on the market, but partnerships are projected to go live in early 2019.

Ads

You May Also Like

PM360 2019 Trailblazer Awards Rare Diseases Brand Champion Julie Baker

Julie Baker, Senior Director, Epidiolex Marketing, Greenwich Biosciences For patients and families affected by ...

2019 Pharma Choice Sales Aid Bronze Winner DiD, Propeller Communications, and Novartis

DiD and Propeller Communications Novartis The Complete COSENTYX Approach: Driving Dialogue Beyond the Skin ...

PM360 2019 Innovative Product Unlimited from Rx EDGE Media Network

Unlimited Rx EDGE Media Network Kathleen Bonetti, Executive Vice President of Marketing  kathleen.bonetti@rx-edge.com People ...